Invention Grant
- Patent Title: Pharmaceutical compositions of goserelin sustained release microspheres
-
Application No.: US15789091Application Date: 2017-10-20
-
Publication No.: US10258572B2Publication Date: 2019-04-16
- Inventor: Wei Sun , Xuemei Zhang , Tao Wang , Guangyi Leng , Kaoxiang Sun , Youxin Li , Wanhui Liu
- Applicant: Shandong Luye Pharmaceutical Co., Ltd.
- Applicant Address: CN Yantai
- Assignee: Shandong Luye Pharmaceutical Co., Ltd.
- Current Assignee: Shandong Luye Pharmaceutical Co., Ltd.
- Current Assignee Address: CN Yantai
- Agency: Seed IP Law Group LLP
- Priority: CN201310136505 20130418
- Main IPC: A61K9/16
- IPC: A61K9/16 ; A61K38/09 ; A61P5/00 ; A61P13/00 ; A61P15/00
Abstract:
A composition of goserelin sustained release microspheres is provided. The microspheres comprise goserelin, at least one poly (lactide-co-glycolide) and poloxamer or PEG. The sustained release microspheres have comparatively high bioavailability, which promotes the drug taking its full effect and have entrapment efficiency over 90%.
Public/Granted literature
- US20180036246A1 PHARMACEUTICAL COMPOSITIONS OF GOSERELIN SUSTAINED RELEASE MICROSPHERES Public/Granted day:2018-02-08
Information query
